Cargando…

Crafting Carbazole-Based Vorinostat and Tubastatin-A-like Histone Deacetylase (HDAC) Inhibitors with Potent in Vitro and in Vivo Neuroactive Functions

[Image: see text] Small-molecule inhibitors of HDACs (HDACi) induce hyperacetylation of histone and nonhistone proteins and have emerged as potential therapeutic agents in most animal models tested. The established HDACi vorinostat and tubastatin-A alleviate neurodegenerative and behavioral conditio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reddy, R. Gajendra, Surineni, Goverdhan, Bhattacharya, Dwaipayan, Marvadi, Sandeep Kumar, Sagar, Arpita, Kalle, Arunasree M., Kumar, Arvind, Kantevari, Srinivas, Chakravarty, Sumana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811854/ https://www.ncbi.nlm.nih.gov/pubmed/31656902 http://dx.doi.org/10.1021/acsomega.9b01950

Ejemplares similares

Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
por: Vanaja, G. R., et al.
Publicado: (2018)

Tubastatin A inhibits HDAC and Sirtuin activity rather than being a HDAC6-specific inhibitor in mouse oocytes
por: Choi, Yun-Jung, et al.
Publicado: (2019)

Fellutamide B Synthetic Path Intermediates with in Vitro Neuroactive Function Shows Mood-Elevating Effect in Stress-Induced Zebrafish Model
por: Reddy, R. Gajendra, et al.
Publicado: (2018)

HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics
por: Araujo-Silva, Carlla Assis, et al.
Publicado: (2020)

Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy
por: Shen, Zhonghai, et al.
Publicado: (2021)

Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015)

The HDAC Inhibitor Vorinostat Diminishes the In Vitro Metastatic Behavior of Osteosarcoma Cells
por: Mu, Xiaodong, et al.
Publicado: (2015)

Axonal Transport Defect in Gigaxonin Deficiency Rescued by Tubastatin A
por: Nath, Banshi, et al.
Publicado: (2023)

Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma
por: Peng, Xiaopeng, et al.
Publicado: (2023)

Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation
por: Debnath, Sudhan, et al.
Publicado: (2019)

Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation
por: Wang, Zhifei, et al.
Publicado: (2016)

HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness
por: Leyk, Janina, et al.
Publicado: (2017)

Effect of vorinostat on INK4 family and HDACs 1, 2, and 3 in pancreatic cancer and hepatocellular carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2021)

Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020)

Natural product based novel small molecules with promising neurotrophic, neurogenic and anti-neuroinflammatory actions can be developed as stroke therapeutics
por: Jhelum, Priya, et al.
Publicado: (2016)

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
por: Saito, Shigeki, et al.
Publicado: (2017)

A bionic multichannel nanofiber conduit carrying Tubastatin A for repairing injured spinal cord
por: Liao, Shiyang, et al.
Publicado: (2022)

Role of 5′TG3′-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition
por: Sharma, Ajay, et al.
Publicado: (2015)

Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy
por: Park, Haeseong, et al.
Publicado: (2016)

Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues
por: Bieszczad, Bartosz, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat
por: Gao, Yali, et al.
Publicado: (2023)

Carbazole-functionalized hyper-cross-linked polymers for CO(2) uptake based on Friedel–Crafts polymerization on 9-phenylcarbazole
por: Fang, Dandan, et al.
Publicado: (2019)

Celecoxib Sensitizes Staphylococcus aureus to Antibiotics in Macrophages by Modulating SIRT1
por: Annamanedi, Madhavi, et al.
Publicado: (2014)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

A 2-oxa-spiro[5.4]decane scaffold displays neurotrophic, neurogenic and anti-neuroinflammatory activities with high potential for development as a versatile CNS therapeutic
por: Joshi, Pranav Chintamani, et al.
Publicado: (2017)

Mono- and multilayers of molecular spoked carbazole wheels on graphite
por: Jester, Stefan-S, et al.
Publicado: (2014)

HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat
por: Angelika Ihle, Michaela, et al.
Publicado: (2016)

Neuroactive Agents and Nerve Membrane Conductances
por: Narahashi, Toshio, et al.
Publicado: (1968)

Neuroactive Steroids: Receptor Interactions and Responses
por: Tuem, Kald Beshir, et al.
Publicado: (2017)

Analytical Methods for the Determination of Neuroactive Steroids
por: Kaleta, Michal, et al.
Publicado: (2021)

Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation
por: Bergadà, Laura, et al.
Publicado: (2014)

Resource Crafting: Is It Really ‘Resource’ Crafting—Or Just Crafting?
por: Hu, Qiao, et al.
Publicado: (2019)

Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
por: Hrzenjak, Andelko, et al.
Publicado: (2010)

Effect of histone deacetylase inhibitor (vorinostat) on new-onset diabetes induced by tacrolimus
por: Bakhdar, Fatmah A., et al.
Publicado: (2022)

Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021)

Managing SARS-CoV2 Infections Through Resolution of Inflammation by Eicosanoids: A Review
por: Mohammed, Ameena, et al.
Publicado: (2022)

Role of Neuroactive Steroids in the Peripheral Nervous System
por: Melcangi, Roberto Cosimo, et al.
Publicado: (2011)

Vitamin D as a Neuroactive Substance: Review
por: Kiraly, Stephen J., et al.
Publicado: (2006)

Delivery of Metabolically Neuroactive Probiotics to the Human Gut
por: Bron, Peter A., et al.
Publicado: (2021)

Development of neuroactive steroids for the treatment of postpartum depression
por: Gunduz‐Bruce, Handan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_75o08k0p0qmk85ra52pdtb4rmu